TuHURA Biosciences (HURA) Cash from Operations (2010 - 2026)

TuHURA Biosciences' Cash from Operations history runs 17 years deep, the most recent figure standing at 4412953.0 for Q1 2026.

• On a quarterly basis, Cash from Operations rose 6.87% year-over-year to 4412953.0 in Q1 2026; TTM through Mar 2026 was 27303681.0, a 13.32% increase from a year earlier, with the FY2025 full-year figure at 27629150.0, down 87.59% from the prior year.
• Cash from Operations rose to 4412953.0 in Q1 2026 per HURA's latest filing, from 5529150.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 3535000.0 in Q2 2023 and bottomed at 12128521.0 in Q3 2024.
• The 5-year median for Cash from Operations is 5529150.0 (2025), against an average of 5376845.13.
• Across the five-year window, Cash from Operations jumped 79.32% in 2023 and tumbled 820.92% in 2024, its largest moves.
• Year by year, Cash from Operations stood at 7213000.0 in 2022, then surged by 52.39% to 3434000.0 in 2023, then slumped by 253.19% to 12128521.0 in 2024, then jumped by 54.41% to 5529150.0 in 2025, then increased by 20.19% to 4412953.0 in 2026.
• Per Business Quant, the three latest HURA Cash from Operations figures stand at 4412953.0 (Q1 2026), 5529150.0 (Q4 2025), and 11113416.0 (Q3 2025).